These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1107 related articles for article (PubMed ID: 25997733)
1. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection. Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733 [TBL] [Abstract][Full Text] [Related]
2. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer. Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135 [TBL] [Abstract][Full Text] [Related]
3. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [TBL] [Abstract][Full Text] [Related]
4. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved. Matsunaga T; Suzuki K; Takamochi K; Oh S Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998 [TBL] [Abstract][Full Text] [Related]
5. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients]. Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316 [TBL] [Abstract][Full Text] [Related]
6. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis. Wang S; Zhou W; Zhang H; Zhao M; Chen X Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223 [TBL] [Abstract][Full Text] [Related]
7. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes. Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630 [TBL] [Abstract][Full Text] [Related]
8. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number. Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511 [TBL] [Abstract][Full Text] [Related]
10. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [TBL] [Abstract][Full Text] [Related]
11. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis. Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer]. Liu JW; Li J; Lin G; Shang XQ Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer. Qiu C; Dong W; Su B; Liu Q; Du J J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264 [TBL] [Abstract][Full Text] [Related]
15. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe. Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920 [TBL] [Abstract][Full Text] [Related]
16. Survival following resection of clinically occult N2 non small cell lung cancer. Dalton R; Keller S J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526 [TBL] [Abstract][Full Text] [Related]
17. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome. Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680 [TBL] [Abstract][Full Text] [Related]